APA (7th ed.) Citation

Q, B., J, N., Q, W., L, S., S, Z., J, B., . . . K, C. (2025). Integrative pan-cancer genomic analysis highlights mitochondrial protein p32 as a potential therapeutic target in Myc-driven tumorigenesis. Medical oncology (Northwood, London, England), 42(3), 60. https://doi.org/10.1007/s12032-025-02604-9

Chicago Style (17th ed.) Citation

Q, Bi, Nie J, Wu Q, Sun L, Zhu S, Bai J, Liu Y, Huang F, and Chai K. "Integrative Pan-cancer Genomic Analysis Highlights Mitochondrial Protein P32 as a Potential Therapeutic Target in Myc-driven Tumorigenesis." Medical Oncology (Northwood, London, England) 42, no. 3 (2025): 60. https://doi.org/10.1007/s12032-025-02604-9.

MLA (9th ed.) Citation

Q, Bi, et al. "Integrative Pan-cancer Genomic Analysis Highlights Mitochondrial Protein P32 as a Potential Therapeutic Target in Myc-driven Tumorigenesis." Medical Oncology (Northwood, London, England), vol. 42, no. 3, 2025, p. 60, https://doi.org/10.1007/s12032-025-02604-9.